Uniquity Bio
Pre-clinicalUniquity Bio is a clinical-stage drug development company dedicated to advancing scientific innovation to deliver novel medicines for patients with immune-mediated diseases.
Founded
2022
Focus
AntibodiesBiologics
About
Uniquity Bio is a clinical-stage drug development company dedicated to advancing scientific innovation to deliver novel medicines for patients with immune-mediated diseases.
Funding History
1Total raised: $100M
Series A$100MARCH Venture PartnersOct 15, 2022
Company Info
TypePrivate
Founded2022
LocationNew York, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile